title: Head and neck cancer in 2010: Maximizing survival and minimizing toxicity.
abstract: Outcomes for patients with oropharyngeal cancer are determined by their tumor characteristics and associated demographics. The role of human papilloma virus-related disease for prognosis and outcomes with chemoradiotherapy is being more clearly defined. EGFR inhibitors are used in conjunction with radiotherapy, and the importance of optimizing radiation quality and minimizing toxicity is the focus of ongoing studies.
authors.affiliation: Division of Hematology/Oncology, NorthShore University HealthSystem, 2650 Ridge Avenue, Room 4816, Evanston, IL 60201, USA. bbrockstein@northshore.org
authors.forename: Bruce E
authors.initials: BE
authors.lastname: Brockstein
authors.forename: Everett E
authors.initials: EE
authors.lastname: Vokes
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000401:mortality* / Q000473:pathology; D006801:Humans; D015996:Survival Rate
chemical_list: D000970:Antineoplastic Agents